Copyright
©The Author(s) 2015.
World J Gastroenterol. Aug 28, 2015; 21(32): 9526-9533
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9526
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9526
Ref. | No. of patients | Severity of liver disease based on CP score | Antiviral scheme (duration) | Virological response |
Curry et al[16] | 61 | ≤ 7 | SOF + RBV (for 48 wk or until LT) | 69% (12 wk after LT) |
Afdhal et al[17] | 40 | 5-10 | SOF + RBV (48 wk) | 100% and 93% for Child class A and B, respectively at 24 wk under treatment |
Gane et al[18] | 20 | 7-9 | SOF + Ledipasvir ± RBV(12 wk) | 89% |
Flamm et al[19] | 108 | Decompensated cirrhosis (CP score range: 7-12) | Ledipasvir/SOF + RBV(12 or 24 wk) | 87% and 89% (for 12 and 24 wk, respectively) |
- Citation: Cholongitas E, Pipili C, Papatheodoridis G. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients. World J Gastroenterol 2015; 21(32): 9526-9533
- URL: https://www.wjgnet.com/1007-9327/full/v21/i32/9526.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i32.9526